These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34977043)

  • 1. Identification of a Six-Gene SLC Family Signature With Prognostic Value in Patients With Lung Adenocarcinoma.
    Zhu J; Mou Y; Ye S; Hu H; Wang R; Yang Q; Hu Y
    Front Cell Dev Biol; 2021; 9():803198. PubMed ID: 34977043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in Osteosarcoma.
    Zheng D; Wei Z; Guo W
    Front Genet; 2022; 13():849789. PubMed ID: 35518353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration.
    Zheng D; Zhang Y; Xia Y; Cheng F
    Front Oncol; 2022; 12():840410. PubMed ID: 35371994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Novel Tumor Microenvironment-Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Ma C; Luo H; Cao J; Zheng X; Zhang J; Zhang Y; Fu Z
    Front Mol Biosci; 2020; 7():571641. PubMed ID: 33102522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis and immunotherapy significances of a cancer-associated fibroblasts-related gene signature in lung adenocarcinoma.
    Luo Y; Zhang S; Xie H; Su Q; He S; Lei Z
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):51-61. PubMed ID: 38279482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma.
    Zhang A; Yang J; Ma C; Li F; Luo H
    Front Cell Dev Biol; 2021; 9():616271. PubMed ID: 34249899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A more novel and powerful prognostic gene signature of lung adenocarcinoma determined from the immune cell infiltration landscape.
    Ma C; Li F; He Z; Zhao S
    Front Surg; 2022; 9():1015263. PubMed ID: 36311939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
    Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
    Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of Immune Implication and Prognostic Value of
    Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
    Front Oncol; 2021; 11():798425. PubMed ID: 35047409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma.
    Ma C; Li F; Luo H
    Ann Transl Med; 2021 Jul; 9(13):1058. PubMed ID: 34422970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a prognostic signature for lung adenocarcinoma by integration of 7 pyroptosis-related genes and cross-validation between the TCGA and GEO cohorts: A comprehensive bioinformatics analysis.
    Zhang W; Wan S; Qu Z; Ge J; Zhang C; Li C; Jiang Y
    Medicine (Baltimore); 2022 Jul; 101(29):e29710. PubMed ID: 35866781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis identifies DNA damage repair-related gene HCLS1 associated with good prognosis in lung adenocarcinoma.
    Liu T; Hu A; Chen H; Li Y; Wang Y; Guo Y; Liu T; Zhou J; Li D; Chen Q
    Transl Cancer Res; 2023 Oct; 12(10):2613-2628. PubMed ID: 37969376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma.
    Jia H; Tang WJ; Sun L; Wan C; Zhou Y; Shen WZ
    Front Genet; 2022; 13():1017866. PubMed ID: 36699466
    [No Abstract]   [Full Text] [Related]  

  • 15. An
    Han Y; Wong FC; Wang D; Kahlert C
    Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.
    Chen J; Fu Y; Hu J; He J
    Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma.
    Cao Y; Lu X; Li Y; Fu J; Li H; Li X; Chang Z; Liu S
    PeerJ; 2020; 8():e10320. PubMed ID: 33344071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma.
    Yang X; Wang G; Gu R; Xu X; Zhu G
    PeerJ; 2020; 8():e10418. PubMed ID: 33304656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
    Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
    Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A signature of estimate-stromal-immune score-based genes associated with the prognosis of lung adenocarcinoma.
    Ma Q; Chen Y; Xiao F; Hao Y; Song Z; Zhang J; Okuda K; Um SW; Silva M; Shimada Y; Si C; Liang C
    Transl Lung Cancer Res; 2021 Mar; 10(3):1484-1500. PubMed ID: 33889524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.